首页|康柏西普治疗视网膜静脉阻塞黄斑水肿的临床分析

康柏西普治疗视网膜静脉阻塞黄斑水肿的临床分析

扫码查看
目的:分析康柏西普治疗视网膜静脉阻塞黄斑水肿的临床疗效。方法:选取2014年4月-2015年1月我院收治的32例(64只眼)视网膜静脉阻塞黄斑水肿患者随机分为对照组(n=16,32只眼)和治疗组(n=16,32只眼),对照组采用雷珠单抗治疗,治疗组采用我院新引进的康柏西普治疗,对比两组治疗效果。结果:治疗组总有效率与对照组相比,差异不具有统计学意义(P>0.05)。结论:康柏西普治疗视网膜静脉阻塞黄斑水肿疗效显著,安全可靠,值得临床使用和推广。
Objective: To analyze the clinical efficacy of retinal vein occlusion, macular edema Compaq Sipp treatment. Methods:32 cases (64 eyes) of macular edema in patients with retinal vein occlusion were randomly in our hospital from 2010 November to 2014 March were randomly divided into a con-trol group (n=16,32 eyes) and treatment group (n=16 , 32 eyes), the control group was treated with ranibizumab ,the treatment group was treated with Compaq Sipp,the treatment were compared in two groups. Results:The total ef iciency of the treatment group compared with the control group, there was not statistical significance (P>0.05). Conclusion:Compaq Sipp treatment of macular edema in retinal vein occlusion effect is significant, safe and reliable, wor-thy of clinical use and promotion.

Macular edemaCompaq SippRetinal vein occlusion

舒智宇

展开 >

四川省成都市第三人民医院 610031

黄斑水肿 康柏西普 视网膜静脉阻塞

2015

延边医学

延边医学

ISSN:
年,卷(期):2015.(12)
  • 5
  • 6